Ulrika
Ulrika Egertsdotter, Marietta, GA US
Patent application number | Description | Published |
---|---|---|
20120258536 | METHOD AND DEVICE FOR DISPERSION OF ASSEMBLIES OF BIOLOGICAL MATERIAL - Methods and devices for dispersion of assemblies of biological material (such as plant embryogenic mass, plant tissue, cultured plant cells, animal tissue and/or cultured animal cells) suspended in a liquid are disclosed. The methods comprise i) subjecting the assemblies of biological material to fluid dynamics forces causing axially extensional strain and radially compressional strain and ii) subjecting the assemblies of biological material to fluid dynamics forces causing axially compressional strain and radially extensional strain fluid dynamics and iii) repeating said steps i) and ii) in sequence until assemblies of biological material is dispersed into the desired smaller size. The devices may comprise a flow channel arranged in a loop configuration for re-circulation in the flow channel, the flow channel including at least one constriction, such that the assemblies of biological material flowing through the flow channel are first subjected to axially extensional strain and radially compressional strain, and then to axially compressional strain and radially extensional strain from fluid dynamics forces. | 10-11-2012 |
20130065306 | METHOD FOR MATURING AND SYNCHRONIZING CONIFER SOMATIC EMBRYOS - A method for the culture of somatic plant embryos comprising contacting said embryos with a culture medium containing a plasmolytic or near plasmolytic concentration of a sugar alcohol or a combination of sugar alcohols; and culturing said embryos in said culture medium for a time period suitable for the desired level of maturation to be achieved. Inositol is a preferable sugar alcohol. | 03-14-2013 |
Ulrika Husmark, Göteborg SE
Patent application number | Description | Published |
---|---|---|
20160128921 | COMPOSITION COMPRISING A BUFFERED LACTIC ACID - A composition including a buffered lactic acid having a pH within the range of from 3.0 to 6.5 is disclosed. The composition is a lubricant composition and has a water activity of from 0.03 to 0.60. The friction between the absorbent product and the skin/mucous membrane of the user is reduced when in contact with the skin or mucous membrane of the user. An additional advantage is that the composition has a pH in the acidic range which is close to the pH of the skin and/or mucous membrane. | 05-12-2016 |
Ulrika Johansson, Enskede SE
Patent application number | Description | Published |
---|---|---|
20100040589 | Novel Compositions and Uses Thereof - The present invention provides a cellular vaccine for therapeutic or prophylactic treatment of a pathological condition, the vaccine comprising or consisting of a population of CD 4 | 02-18-2010 |
20110300179 | Novel Compositions and Uses Thereof - The present invention provides a cellular vaccine for therapeutic or prophylactic treatment of a pathological condition, the vaccine comprising or consisting of a population of CD 4+ T cells modified such that they contain an antigenic component, and/or a nucleic acid molecule encoding an antigenic component thereof, wherein the T cells are (a) activated, or capable of being activated, and (b) apoptotic, or capable or being made apoptotic. The invention further provides an adjuvant composition for use in a method of vaccination, the composition comprising or consisting of a population of T cells, wherein the T cells are (a) activated, or capable of being activated, and (b) apoptotic, or capable or being made apoptotic. In addition, the invention provides a composition having microbicide activity, or capable thereof upon exposure to antigen-presenting cells, the composition comprising or consisting of a population of T cells, wherein the T cells are (a) activated, or capable of being activated, and (b) apoptotic, or capable or being made apoptotic. Also provided by the present invention are methods for making and using the vaccines and compositions described herein. | 12-08-2011 |
Ulrika Johansson, Enskede CH
Patent application number | Description | Published |
---|---|---|
20090263421 | CELLULAR VACCINE - The present invention provides a cellular vaccine for therapeutic or prophylactic treatment of a pathological condition, the vaccine comprising or consisting of a population of CD 4 | 10-22-2009 |
Ulrika Libander, Saro SE
Patent application number | Description | Published |
---|---|---|
20090036849 | Absorbent Article - An absorbent article such as a sanitary napkin, panty liner, tampon, diaper, pant diaper, adult incontinence guard, provided with at least one capsule ( | 02-05-2009 |
Ulrika Lidstrom, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20130116126 | COMPOSITIONS AND METHODS FOR IDENTIFYING AND MODIFYING CARBONACEOUS COMPOSITIONS - This invention generally relates to natural gas and methylotrophic energy generation, bio-generated fuels and microbiology. In alternative embodiments, the invention provides nutrient amendments and microbial compositions, e.g., consortia, that are both specifically optimized to stimulate methanogenesis, or for “methylotrophic” or other conversions. In alternative embodiments, the invention provides methods to develop nutrient amendments and microbial compositions that are both specifically optimized to stimulate methanogenesis in a given reservoir. The invention also provides methods for the evaluation of potentially damaging biomass formation and scale precipitation resulting from the addition of nutrient amendments. In other embodiments, the invention provides methods for simulating biogas in sub-surface conditions using a computational model. | 05-09-2013 |
20160108435 | COMPOSITIONS AND METHODS FOR IDENTIFYING AND MODIFYING CARBONACEOUS COMPOSITIONS - This invention generally relates to natural gas and methylotrophic energy generation, bio-generated fuels and microbiology. In alternative embodiments, the invention provides nutrient amendments and microbial compositions, e.g., consortia, that are both specifically optimized to stimulate methanogenesis, or for “methylotrophic” or other conversions. In alternative embodiments, the invention provides methods to develop nutrient amendments and microbial compositions that are both specifically optimized to stimulate methanogenesis in a given reservoir. The invention also provides methods for the evaluation of potentially damaging biomass formation and scale precipitation resulting from the addition of nutrient amendments. In other embodiments, the invention provides methods for simulating biogas in sub-surface conditions using a computational model. | 04-21-2016 |
Ulrika Linné, Lund SE
Patent application number | Description | Published |
---|---|---|
20130094993 | ASSEMBLY AND METHOD FOR REDUCING FOIL WRINKLES - An assembly of a support plate and an exit window foil for use in an electron beam generating device. The support plate is designed to reduce wrinkles in the foil. The foil is bonded to the support plate along a closed bonding line bounding an area in which the support plate is provided with a pattern of apertures and foil support portions alternately. When vacuum is created in the housing the pattern is adapted to form a topographical profile of the foil substantially absorbing any surplus foil. Another aspect involves a method in a filling machine for sterilizing a packaging material web. | 04-18-2013 |
Ulrika Linné, Lund SE
Patent application number | Description | Published |
---|---|---|
20130000253 | ASSEMBLY AND METHOD FOR REDUCING FOIL WRINKLES - An assembly of a support plate and an exit window foil for use in an electron beam device. The support plate is designed to reduce wrinkles in said foil, which wrinkles may arise due to surplus foil arising in the assembly process. The foil is being bonded to the support plate along a closed bonding line bounding a substantially circular area in which the support plate is provided with apertures and foil support portions and in which area the foil is adapted to serve as a portion of a wall of a vacuum tight housing of the electron beam device. Another aspect involves a method for using the assembly in a filling machine, as well as a method of reducing wrinkles. | 01-03-2013 |
20130094993 | ASSEMBLY AND METHOD FOR REDUCING FOIL WRINKLES - An assembly of a support plate and an exit window foil for use in an electron beam generating device. The support plate is designed to reduce wrinkles in the foil. The foil is bonded to the support plate along a closed bonding line bounding an area in which the support plate is provided with a pattern of apertures and foil support portions alternately. When vacuum is created in the housing the pattern is adapted to form a topographical profile of the foil substantially absorbing any surplus foil. Another aspect involves a method in a filling machine for sterilizing a packaging material web. | 04-18-2013 |
Ulrika Meyer, Uppsala SE
Patent application number | Description | Published |
---|---|---|
20100294977 | SEPARATION OF BIOMOLECULES - The present invention relates to separation of biomolecules. More closely, the invention relates to a method for production of a separation medium comprising hybrid particles of inorganic and organic material as well as the hybrid particles produced by this method. Finally, the invention relates to use of the hybrid particles for separation of biomolecules, preferably phosphoproteins. The method comprises the following steps: addition of inorganic metal oxide particles to an organic solution to form a mixture; and emulsification of the mixture to form porous hybrid particles, wherein the density of the porous hybrid particles is between 1.0 and 1.5 g/ml, and wherein the inorganic particles have a shape and size that maximizes their active surface area enabling the inorganic particles to interact with biomolecules. | 11-25-2010 |
Ulrika Persson, Kungsbacka SE
Patent application number | Description | Published |
---|---|---|
20090259208 | HYDROENTANGLED NONWOVEN FABRIC, METHOD OF MAKING IT AND ABSORBENT ARTICLE CONTAINING THE FABRIC - A nonwoven fabric comprising at least 50% by weight microfibers having a fineness of 1.0 dtex or less and a length of at least 30 mm and having been combined by hydroentangling. The fabric is apertured by said hydroentangling, and has been carded before hydroentangling. The fabric may be used as a topsheet material on an absorbent article. | 10-15-2009 |
Ulrika Persson, Helsingborg SE
Patent application number | Description | Published |
---|---|---|
20110014491 | IRON-CHROMIUM BASED BRAZING FILLER METAL - An iron-chromium based brazing filler metal is provided which exhibits an excellent wetting behavior on a stainless steel base material. The brazing filler metal produces a brazed joint which exhibits high strength and good corrosion resistance. The brazing filler metal is suitable for brazing stainless steel and other materials where corrosion resistance and high strength is required. Typical examples of applications are heat exchangers and catalytic converters. The iron-chromium based brazing filler metal powder according to the invention comprises: between 11 and 35 wt % chromium, between 0 and 30 wt % nickel, between 2 and 20 wt % copper, between 2 and 6 wt % silicon, between 4 and 8 wt % phosporous, between 0-10 wt % manganese, and at least 20 wt % iron. | 01-20-2011 |
Ulrika Rosenström, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20140329839 | New Crystalline Form of Pemirolast - There is provided a hemihydrate form of the sodium salt of pemirolast. | 11-06-2014 |
Ulrika Rosentrôm, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20120157415 | New Crystalline Form of Pemirolast - There is provided a hemihydrate form of the sodium salt of pemirolast. | 06-21-2012 |
Ulrika Rova US
Ulrika Vejbrink, Bromma SE
Patent application number | Description | Published |
---|---|---|
20100193536 | BLISTER PACK DEVICE AND A METHOD OF EJECTING A UNIT DOSAGE FROM A BLISTER PACK USING THE DEVICE - The present invention relates to a blister pack device for dispensing a dosage unit from a blister pack. The blister pack has at least one blister and a lid foil. The device comprises a first arm and a second lever arm hingedly connected to each other, the first arm comprises an aperture through which the dosage unit can be ejected. The lever arm comprises a protruding member for pressing out a dosage unit from the blister when the lever arm is lowered down onto the blister positioned on the first arm. The protruding member comprises a first section for applying a pressing force on the dosage unit inside the blister to initiate the breaking of the lid foil of the blister pack and a second section for distributing the pressing force over the dosage unit and for ejecting the dosage unit. | 08-05-2010 |
Ulrika Vejbrink, Hagersten SE
Patent application number | Description | Published |
---|---|---|
20140014692 | BABY CARRIER - A baby carrier comprising chest straps, a waist belt and a carrier bag mounted to the chest straps and the waist belt, the carrier bag comprises a front piece, a lower portion of the front piece being connected to the waist belt. A connection between the chest straps is adapted to be achieved by a means, and a second part of respective chest strap is connected to a middle portion of the front piece so as to permit the baby carrier to be rotated around an upper part of the body of a wearer, whereby, during one step of the rotation of the baby carrier, the means extends over one shoulder of the wearer and carries the weight which in the normal case is carried by the chest straps. | 01-16-2014 |
Ulrika Yngve, Sodertalje SE
Patent application number | Description | Published |
---|---|---|
20090192190 | Benzoic Acid Derivatives that are Modulators or Agonists of GlyR - Compounds of formula I, | 07-30-2009 |
20100234593 | Imidazo[4,5-B]Pyridine-7-Carboxamides 704 - The present invention relates to new compounds of formula (I) as a free base or a pharmaceutically acceptable salt, solvate or solvate of salt thereof, a process for their preparation and new intermediates used therein, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy. | 09-16-2010 |
20100267723 | Imidazole Substituted Pyrimidines - A compound of formula (I) | 10-21-2010 |
20110118275 | OXAZOLO[4,5-c]PYRIDINE SUBSTITUTED PYRAZINE - The present invention relates to a compound of formula (I) | 05-19-2011 |
20120077813 | Imidazole Substituted Pyrimidines Useful in the Treatment of Glycogen Synthase Kinase-3 Related Disorders such as Alzheimer's Disease - The present invention relates to a new compound of formula (I) wherein R | 03-29-2012 |